Profile
Sector:
Consumer CyclicalIndustry:
Personal ServicesCountry:
United StatesIPO:
30 December 1993Website:
http://medifastinc.comNext earnings report:
N/ALast dividends:
18 September 2023Next dividends:
N/APrice
pre-market | 15 min agoAnalysts recommendations
Institutional Ownership
Included in screeners
MED Latest News
Medifast's Q3 results lower earnings and revenues, highlighting challenges in customer acquisition. Management issues soft guidance for the fourth quarter.
Medifast, Inc. (NYSE:MED ) Q3 2024 Earnings Conference Call November 4, 2024 4:30 PM ET Company Participants Steven Zenker - Vice President-Investor Relations Dan Chard - Chairman & Chief Executive Officer Jim Maloney - Chief Financial Officer Conference Call Participants Jim Salera - Stephens Inc. Linda Bolton-Weiser - D.A. Davidson Operator Greetings, and welcome to the Medifast Third Quarter 2024 Earnings Conference Call.
MED is striving to excel in the evolving weight loss market where GLP-1 medication adoption is reshaping the industry dynamics amid macroeconomic challenges.
LOS ANGELES, CA / ACCESSWIRE / September 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
LOS ANGELES, CA / ACCESSWIRE / September 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
LOS ANGELES, CA / ACCESSWIRE / September 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
LOS ANGELES, CA / ACCESSWIRE / September 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
LOS ANGELES, CA / ACCESSWIRE / September 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
LOS ANGELES, CA / ACCESSWIRE / September 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
LOS ANGELES, CA / ACCESSWIRE / September 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
What type of business is Medifast?
Medifast, Inc. is an American company that specializes in the development, production, and sales of special nutrition and weight control programs, as well as products for a healthy lifestyle. The company is based in Baltimore, Maryland and was founded in 1980. Medifast, Inc.'s products and programs are developed in collaboration with scientists and doctors specifically for clients to help them achieve optimal weight and get into a healthy shape. The company's products focus on developing the right dietary plan for each client, motivation and workout programs, and instilling healthy habits.
What sector is Medifast in?
Medifast is in the Consumer Cyclical sector
What industry is Medifast in?
Medifast is in the Personal Services industry
What country is Medifast from?
Medifast is headquartered in United States
When did Medifast go public?
Medifast initial public offering (IPO) was on 30 December 1993
What is Medifast website?
https://medifastinc.com
Is Medifast in the S&P 500?
No, Medifast is not included in the S&P 500 index
Is Medifast in the NASDAQ 100?
No, Medifast is not included in the NASDAQ 100 index
Is Medifast in the Dow Jones?
No, Medifast is not included in the Dow Jones index
When was Medifast the previous earnings report?
No data
When does Medifast earnings report?
Next earnings report date is not announced yet